Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Psychiatry Research|October 1, 1985
Apomorphine has no effect on plasma homovanillic acid in schizophrenic patientsM Davidson, K S Kendler, B M Davis, et al.
Human Gene Therapy|May 1, 1999
DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenograftsO N Koç, J S Reese, B M Davis, et al.
Seminars in Oncology|February 1, 1996
Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy toleranceO N Koç, J A Allay, K Lee, et al.
The Journal of Comparative Neurology|October 7, 1996
Excess nerve growth factor in the periphery does not obscure development of whisker-related patterns in the rodent brainS Jhaveri, R S Erzurumlu, E D Laywell, et al.
The Journal of Comparative Neurology|February 25, 1992
Axonal sprouting and frank regeneration in the lizard tail spinal cord: correlation between changes in synaptic circuitry and axonal growthM T Duffy, D R Liebich, L K Garner, et al.
Cancer Research|November 26, 1997
Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosoureaB M Davis, J S Reese, O N Koç, et al.
Human Gene Therapy|December 10, 1999
Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapyB M Davis, J C Roth, L Liu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1995
NGF modulates sympathetic innervation of lymphoid tissuesS L Carlson, K M Albers, D J Beiting, et al.
Brain Research|June 10, 1996
Effects of NGF overexpression on anatomical and physiological properties of sympathetic postganglionic neuronsB M Davis, H S Wang, K M Albers, et al.
Psychiatry Research|May 1, 1983
Gamma-hydroxybutyrate in the treatment of schizophreniaM I Levy, B M Davis, R C Mohs, et al.
Pageof 14